Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

1,406 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 298
Recruiting: 144
Ph III recruiting: 19
Growth YoY: −14%
Industry share: 35%
Top sponsor: City of Hope Medical Center
Termination share: 34.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (273)

clinicaltrialsPublishedShowing 101–114 of 114 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01295593	Low Dose CdA Combined With Valproic Acid (VPA) in Previously Treated B-cell Chronic Lymphocytic Leukemia(B-CLL)	unknown	Phase 1 / Phase 2	33	Cliniques universitaires Saint-Luc- Université Catholique de LouvainOTHER	1	Jun 7, 2012	clinicaltrials
NCT01051115	Dasatinib Combination for Chronic Lymphocytic Leukemia(CLL) With Refractory Disease(D'ACCORD)	unknown	Phase 2	35	Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)